Pulmonary Aerosol Delivery


  • Development and validation of innovative methods for aerosolized delivery of drugs to animal models and pulmonary cell systems
  • Further improvement of the recently developed ALICE-CLOUD technology (ALICE: Air-Liquid Interface Cell Exposure) for dosimetrically accurate and technologically simple in vitro application of liquid drugs to lung cells cultured at air-liquid interface conditions
  • Establishment of optical imaging techniques (fluorescence, bioluminescence)  for analysis of regional distribution and bioactivity of drugs delivered to in vitro cell systems or murine lungs
  • Development of bioreactors for improved, cell-based drug screening under physiologically realistic conditions (e.g. air-liquid interface cell cultures; co-culture cell models; periodically stretched cells)
  • Preclinical targeting of (bio-)therapeutics and nano-drug-carrier systems to specific regions or cell types of the murine lung
  • Dosimetry of cigarette smoke in biological tissue

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.